- Home
- ATXS vs PRTH Comparison
ATXS vs PRTH Comparison
Compare ATXS & PRTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- PRTH
- Stock Information
- Founded
- ATXS 2008
- PRTH 2005
- Country
- ATXS United States
- PRTH United States
- Employees
- ATXS N/A
- PRTH 983
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- PRTH EDP Services
- Sector
- ATXS Health Care
- PRTH Technology
- Exchange
- ATXS Nasdaq
- PRTH Nasdaq
- Market Cap
- ATXS 669.8M
- PRTH 613.9M
- IPO Year
- ATXS 2015
- PRTH N/A
- Fundamental
- Price
- ATXS $9.37
- PRTH $7.99
- Analyst Decision
- ATXS Strong Buy
- PRTH Buy
- Analyst Count
- ATXS 5
- PRTH 2
- Target Price
- ATXS $25.60
- PRTH $11.00
- AVG Volume (30 Days)
- ATXS 219.2K
- PRTH 114.4K
- Earning Date
- ATXS 11-13-2024
- PRTH 11-07-2024
- Dividend Yield
- ATXS N/A
- PRTH N/A
- EPS Growth
- ATXS N/A
- PRTH N/A
- EPS
- ATXS N/A
- PRTH N/A
- Revenue
- ATXS N/A
- PRTH $851,914,000.00
- Revenue This Year
- ATXS N/A
- PRTH $18.77
- Revenue Next Year
- ATXS N/A
- PRTH $11.36
- P/E Ratio
- ATXS N/A
- PRTH N/A
- Revenue Growth
- ATXS N/A
- PRTH 16.08
- 52 Week Low
- ATXS $4.26
- PRTH $2.79
- 52 Week High
- ATXS $16.90
- PRTH $8.90
- Technical
- Relative Strength Index (RSI)
- ATXS 30.44
- PRTH 67.23
- Support Level
- ATXS $11.40
- PRTH $5.01
- Resistance Level
- ATXS $11.75
- PRTH $8.90
- Average True Range (ATR)
- ATXS 0.75
- PRTH 0.50
- MACD
- ATXS -0.23
- PRTH 0.29
- Stochastic Oscillator
- ATXS 7.64
- PRTH 76.61
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.